How AI is finding cancer treatments with fewer side-effects | BBC News

Lab Genius in London is utilizing Robotics and AI to enhance immunotherapy treatments for cancer, focusing on developing molecules that target cancer cells with fewer side effects. By leveraging machine learning algorithms and automated platforms, they aim to accelerate the discovery of high-performing cancer treatments and potentially revolutionize the way cancer is treated in the future.

In recent years, cancer treatment has shifted towards a more personalized approach, moving away from a one-size-fits-all chemotherapy regimen. Immunotherapy has emerged as a promising alternative, utilizing drugs that work in tandem with the body’s immune system to target and kill cancer cells. Lab Genius, a scientific facility in London, is leveraging the power of Robotics and AI to enhance immunotherapy treatments. Their approach involves automated machines and algorithms to design experiments and analyze data, aiming to develop more effective immunotherapy solutions.

Lab Genius utilizes a smart robotic platform that synthesizes, purifies, and tests molecules using machine learning techniques. By harnessing cloud computing capabilities, they can efficiently test the purity and scalability of these molecules. The lab’s unique methodology has shown promising results, with machine learning models producing molecules with significantly enhanced killing selectivity. This approach has the potential to accelerate the discovery of high-performing cancer treatments compared to traditional methods.

Their focus lies on developing molecules targeting surface markers on cancer cells, known as immune cell engages. These molecules aim to engage immune cells to specifically target cancer cells, minimizing collateral damage. Lab Genius’s targeted immunotherapy approach represents a more precise and effective method of treatment, allowing for stronger attacks on cancer cells with fewer side effects. This advancement in preclinical development, supported by streamlined regulatory processes, suggests a potential reduction in the time required to bring new treatments to market.

Despite the progress in cancer treatment, the question of whether cancer can be completely cured remains unanswered. However, advancements in understanding biology and the development of more targeted therapies offer hope for improving the survival rates and quality of life for cancer patients. Lab Genius believes that by combining human ingenuity with machine intelligence, they can continue to innovate and expedite the discovery of novel cancer treatments, potentially revolutionizing the way cancer is treated in the future.